Extendicare (TSE:EXE) Reaches New 1-Year High – Should You Buy?

Extendicare Inc. (TSE:EXE) shares reached a new 52-week high during trading on Monday . The company traded as high as C$27.44 and last traded at C$26.56, with a volume of 57784 shares changing hands. The stock had previously closed at C$26.58.

Analyst Ratings Changes

Several equities research analysts have issued reports on EXE shares. TD Securities raised their price target on shares of Extendicare from C$15.00 to C$19.00 in a research note on Thursday, November 13th. Cormark upped their price objective on shares of Extendicare from C$25.00 to C$30.00 in a research note on Wednesday, December 3rd. National Bank Financial lifted their target price on shares of Extendicare from C$24.50 to C$29.00 and gave the stock an “outperform” rating in a research note on Thursday, February 5th. BMO Capital Markets upgraded Extendicare from a “hold” rating to an “outperform” rating and boosted their price target for the company from C$21.00 to C$24.00 in a report on Thursday, December 4th. Finally, Royal Bank Of Canada upgraded Extendicare from a “hold” rating to a “moderate buy” rating and raised their price objective for the stock from C$15.00 to C$25.00 in a report on Thursday, December 4th. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Buy” and an average price target of C$24.50.

Extendicare Price Performance

The company has a debt-to-equity ratio of 283.02, a current ratio of 0.62 and a quick ratio of 0.98. The stock has a market cap of C$2.51 billion, a price-to-earnings ratio of 25.08 and a beta of 1.30. The firm’s 50-day moving average is C$23.08 and its 200 day moving average is C$18.80.

Extendicare (TSE:EXE) last announced its quarterly earnings results on Thursday, February 26th. The company reported C$0.29 earnings per share for the quarter. The company had revenue of C$462.03 million for the quarter. Extendicare had a net margin of 4.48% and a return on equity of 64.13%. Sell-side analysts anticipate that Extendicare Inc. will post 0.6134729 earnings per share for the current fiscal year.

About Extendicare

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.